STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
公司代碼STAA
公司名稱STAAR Surgical Co
上市日期Feb 24, 1992
CEOFarrell (Stephen C)
員工數量1157
證券類型Ordinary Share
年結日Feb 24
公司地址1911 Walker Ave
城市MONROVIA
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編91016
電話16263037902
網址https://www.staar.com/
公司代碼STAA
上市日期Feb 24, 1992
CEOFarrell (Stephen C)